| COL17A1 |
|---|
|
| Identifiers |
|---|
| Aliases | COL17A1, BA16H23.2, BP180, BPA-2, BPAG2, LAD-1, ERED, collagen type XVII alpha 1, collagen type XVII alpha 1 chain, JEB4 |
|---|
| External IDs | OMIM: 113811; MGI: 88450; HomoloGene: 133558; GeneCards: COL17A1; OMA:COL17A1 - orthologs |
|---|
|
| Gene location (Mouse) |
|---|
| | Chr. | Chromosome 19 (mouse) |
|---|
| | Band | 19 D1|19 40.07 cM | Start | 47,634,783 bp |
|---|
| End | 47,680,533 bp |
|---|
|
|
|
|
| Wikidata |
|
Collagen XVII, previously called BP180, is a transmembrane protein which plays a critical role in maintaining the linkage between the intracellular and the extracellular structural elements involved in epidermal adhesion, identified by Diaz and colleagues in 1990.
COL17A1 is the official name of the gene. It encodes the alpha chain of type XVII collagen. Collagen XVII is a transmembrane protein, like collagen XIII, XXIII and XXV. Collagen XVII is a structural component of hemidesmosomes, multiprotein complexes at the dermal-epidermal basement membrane zone that mediate adhesion of keratinocytes to the underlying membrane. It also appears to be a key protein in maintaining the integrity of the corneal epithelium. Mutations in this gene are associated with both generalized atrophic benign and junctional epidermolysis bullosa, as well as recurrent corneal erosions, and expression of this gene is abnormal in various cancers. Two homotrimeric forms of type XVII collagen exist. The full length form is the transmembrane protein. A soluble form, referred to as either ectodomain or LAD-1, is generated by proteolytic processing of the full length form.